Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE: HAE) revealed its financial results for the fourth quarter of fiscal 2021, which ended on April 3, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics Corporation (NYSE: HAE) revealed its financial results for the fourth quarter of fiscal 2021, which ended on April 3, 2021. The results can be accessed on the company's Investor Relations website. Following the release, a conference call and webcast will be held on May 13, 2021, at 8:00 a.m. ET, allowing investors to engage with management and learn more about the results. The company’s offerings support healthcare improvements in blood and plasma collection, surgical services, and hospital transfusions. Detailed earnings information is also available through direct links provided in the announcement.
Details
News Market Reaction – HAE
The recorded move for HAE in the trading session of this news was -13.40%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, May 13, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal 2021, which ended April 3, 2021, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 13, 2021. The conference call and webcast can be accessed with the following information:
- U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
- Conference ID required for access: 8694785
- A live webcast of the call can be accessed on Haemonetics' Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/xqyzme3t
In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.
Direct link to 4Q FY21 Earnings Release:
https://haemonetics.gcs-web.com/static-files/481f6d1e-dc52-460a-9c68-776987d4e6c1
Direct link to 4Q FY21 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/aedee021-4974-49c9-97bb-aaa441c4fc95
A replay of the conference call and webcast will be available for one year beginning on May 13, 2021 at 11:00 a.m. ET using the conference call webcast link provided in this press release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contact | Media Contact |
Olga Guyette, Director-Investor Relations | Carla Burigatto, VP-Communications |
(781) 356-9763 | (781) 348-7263 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-4th-quarter-fiscal-year-2021-earnings-release-available-on-investor-relations-website-301290557.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.